Retinal Vascular

Ophthalmology
0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
3 programs
OCT AngiographyN/A1 trial
OCT AngiographyN/A1 trial
OCT AngiographyN/A1 trial
Active Trials
NCT03530449Terminated39Est. Sep 2018
NCT03279939Completed88Est. Jan 2018
NCT04604002Completed86Est. Jan 2022
Zilia
ZiliaRIO DE JANEIRO, Brazil
1 program
Zilia OcularN/A1 trial
Active Trials
NCT04408677Terminated33Est. Sep 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ZiliaZilia Ocular
Heidelberg PharmaOCT Angiography
Heidelberg PharmaOCT Angiography
Heidelberg PharmaOCT Angiography

Clinical Trials (4)

Total enrollment: 246 patients across 4 trials

NCT04408677ZiliaZilia Ocular

Normative Data Collection Study of the Zilia Ocular for the Measurement of Oxygen Saturation in the Retina

Start: Jun 2021Est. completion: Sep 202133 patients
N/ATerminated

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

Start: Oct 2020Est. completion: Jan 202286 patients
N/ACompleted

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Start: Apr 2018Est. completion: Sep 201839 patients
N/ATerminated

Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Start: Aug 2017Est. completion: Jan 201888 patients
N/ACompleted

Related Jobs in Ophthalmology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space